Contact
Please use this form to send email to PR contact of this press release:
La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza™ (angiotensin II)
TO:
Please use this form to send email to PR contact of this press release:
La Jolla Pharmaceutical Company Announces FDA Approval of Giapreza™ (angiotensin II)
TO: